Clinical trial Recruiting at 1 site Interventional Ages 8 to 17

Cognitive training with brain stimulation for children with fetal alcohol exposure

Official title: tDCS and Cognitive Training as a Neurodevelopmental Intervention in FASD

Run by University of Minnesota · NCT05456321 · Data updated 2026-11-12

This study is testing whether a combination of brain training and gentle brain stimulation can help children and teens who were exposed to alcohol before birth improve their thinking and learning skills.

Quick facts

Study typeInterventional
Ages8 Years to 17 Years
SexAll
Enrollment70 (estimated)
SponsorUniversity of Minnesota
Academic / other
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedNovember 10, 2022
Main results expectedMay 31, 2027
Study endsMay 31, 2027
Registry record updatedJanuary 20, 2026
Trial IDNCT05456321 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children and adolescents aged 8 to 17 years with documented heavy prenatal alcohol exposure and a diagnosis of Fetal Alcohol Spectrum Disorders.

Probably not a fit

Patients with substance abuse issues, serious psychiatric disorders, or other neurological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial investigates the effects of cognitive training combined with transcranial direct current stimulation (tDCS) on children and adolescents aged 8 to 17 years who have been prenatally exposed to alcohol. It is a randomized, placebo-controlled study that includes a baseline cognitive assessment, followed by five sessions of tDCS, with participants receiving either active or sham stimulation. The study aims to address the neurocognitive impairments associated with Fetal Alcohol Spectrum Disorders (FASD) and evaluate improvements in learning, attention, and decision-making skills. A follow-up cognitive assessment will be conducted after the intervention to measure outcomes.

Why it matters

Potential benefit: If successful, this study could provide new therapeutic options to improve cognitive functioning in children affected by prenatal alcohol exposure.

How similar studies have gone: While there have been few treatment studies for FASD, this approach combining cognitive training with tDCS is relatively novel and has not been extensively tested in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Documented heavy prenatal alcohol exposure (self-report, social service records, or adoption records) and meeting criteria for an associated FASD diagnosis (FAS, partial FAS, or ARND).
* An available parent or legal guardian capable of giving informed consent

Exclusion Criteria:

* Substance abuse in the participant
* Neurological condition or other developmental disorder
* Serious psychiatric disorder known to affect brain functioning and cognitive performance Birthweight \< 1500 grams
* MRI contraindication
* tDCS contraindication

Where it's running

  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: Jeffrey R Wozniak, Ph.D. — University of Minnesota
  • Study coordinator: Jeffrey Wozniak, PhD
  • Email: jwozniak@umn.edu
  • Phone: 1-612-598-0041

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.